Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis
- Juha Tuokkoa,
- Helena Reijonenb,
- Jorma Ilonenb,
- Kaisa Anttilab,
- Simo Nikkaria,
- Timo Möttönenc,
- Urpo Yli-Kerttulad,
- Auli Toivanenc
- aTurku University, Turku, Finland: Turku Immunology Centre and Department of Medical Microbiology , bDepartment of Virology , cTurku University Central Hospital, Turku, Finland: Division of Rheumatology, Department of Medicine , dTampere University Hospital, Tampere, Finland: Division of Rheumatology, Department of Medicine
- Juha Tuokko MD, Department of Medical Microbiology, Turku University, Kiinamyllynkatu 13, FIN-20520, Turku, Finland.
- Accepted 21 October 1996
Abstract
OBJECTIVE To study HLA class II association in reactive arthritis.
METHODS 63 patients with reactive arth-ritis and 46 with rheumatoid arthritis were included in the study. HLA-DR alleles were determined by using a sequence specific PCR method. Oligonucleotide hybridisation was used for definition of DRB1*04 subtypes and DQB1 alleles. HLA-B27 was determined by standard microcytotoxity test or by PCR. HLA-B27 subtyping was made by sequencing.
RESULTS 46 (73%) of 63 patients with reactive arthritis were HLA-B27 positive and 24 (38%) were HLA-DRB1*04 positive. When haplotypes were inferred according to the known associations between DRB1 and DQB1 alleles, the frequency of DRB1*04-DQB1*0301 haplotype was found to be 13% (12/92) in HLA-B27 positive reactive arthritis patients, in contrast to 0% in HLA-B27 negative reactive arthritis (P = 0.04) and 1% in random controls (P = 0.0009). However, this combination was also found in 5% of 84 HLA-B27 positive control haplotypes, showing a linkage disequilibrium between B27 and this particular class II haplotype. HLA-DRB1*0408 subtype was found in 8/24 (33%) of the HLA-DRB1*04 alleles in patients with reactive arthritis, accounting for most DQB1*0301 haplotypes, but only in 5/55 (9%) of the DRB1*04 alleles in random controls (P = 0.017). All reactive arthritis patients with this subtype were positive for HLA-B27. DRB1*04-DQB1*0302 haplotype was increased in patients with rheumatoid arthritis (28/92, 30%) compared with reactive arthritis (12/126, 10%) or with the controls (12/100, 12%; P = 0.003). HLA-B*2705 was by far the dominant B27 subtype both in reactive arthritis patients with the particular DRB1*0408-DQB1*0301 haplotype and in controls. It was found in 11 out of 12 DR analysed patients, as well as in 10 out of 11 randomly selected B27 positive controls.
CONCLUSIONS Although no single class II allele was found to be increased among patients with reactive arthritis, HLA-B27, DRB1*0408, and DQB1*0301 might exert a haplotypic effect in the pathogenesis of reactive arthritis, or they may be markers of a subset of B27 haplotypes conferring susceptibility.
